(Q35595964)

English

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease

scientific article published on October 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

monoclonal antibody

1 reference

based on heuristic

inferred from title

autoimmune disease

1 reference

based on heuristic

inferred from title

author name string

van der Lubbe P

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

G. Riethmüller

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

E. P. Rieber

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

S. Kiefersauer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

J. Prinz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

P. van der Lubbe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

B. Meiser

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

F. Breedveld

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

J. Eisenburg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

K. Krüger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

K. Deusch

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1464423

29 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1464423

29 September 2022

publication date

1 October 1992

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Immunological Reviews

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

81-104

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

The biologic roles of CD2, CD4, and CD8 in T-cell activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Autoimmunity, microbial immunity and the immunological homunculus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Enhanced expression of HLA-class II molecules on activated human T lymphocytes following treatment with tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Interaction between CD4 and class II MHC molecules mediates cell adhesion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

CD4 antibody treatment of severe psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Signal for T-cell differentiation to a CD4 cell lineage is delivered by CD4 transmembrane region and/or cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Monoclonal anti-CD4 in arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Anti-CD4 monoclonal antibody administration in renal transplanted patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Immunochemical analysis of the surface of the sea urchin egg; an approach to the study of fertilization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Monoclonal CD4 antibodies after accidental HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Anti-CD4 monoclonal antibody for relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01420.X

21 January 2018

Identifiers

10.1111/J.1600-065X.1992.TB01420.X

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35595964&oldid=1967333357"